Evidence map›Paper›PMID 11226286›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.

D Fukumura, T Gohongi, A Kadambi, Y Izumi, J Ang, C O Yun, D G Buerk, P L Huang, R K Jain

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 384 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
384citing papers in PubMed, 1 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

384 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,007 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Ischemic Preconditioning Improves Handgrip Strength and Functional Capacity in Active Elderly Women.International journal of environmental research and public health · 2022
    Trial
  4. AA in Hypertension and Preeclampsia.Reviews of physiology, biochemistry and pharmacology · 2027
    Review
  5. Article
  6. Angiogenic Doping: Plausible Yet Difficult to Detect.Sports medicine (Auckland, N.Z.) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Effect of allopurinol and oxypurinol treatment on apoptosis in an experimental testicular torsion model.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  16. Review
  17. Article
  18. Development of the Cardiovascular System During Adolescence.Advances in experimental medicine and biology · 2026
    Review
  19. Article
  20. Review

324 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

D FukumuraEdwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom Street, Boston, MA 02114, USA. dai@steele.mgh.harvard.edu
T Gohongi
A Kadambi
Y Izumi
J Ang
C O Yun
D G Buerk
P L Huang
R K Jain
Massachusetts General Hospital · USHarvard University · USUniversity of Pennsylvania · US

Funding

Vascular Normalization: Rolse of Perivascular CellsP01CA080124 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2000 to 2016
$35.0M
BIOLOGY OF TUMOR ANGIOGENESIS, INVASION AND METASTASISR24CA085140 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2000 to 2004
$8.3M
REGULATION OF CEREBRAL BLOOD FLOWR01NS033335 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, PAUL L. · 1994 to 2012
$4.2M
NITRIC OXIDE SYNTHASE ISOFORMS IN ATHEROSCLEROSISR01HL057818 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, PAUL L. · 1998 to 2006
$1.8M
MICROELECTRODE AND BLOOD FLOW STUDIES IN OPTIC NERVER01EY009269 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BUERK, DONALD G · 1992 to 2000
$227k
PATHOPHYSIOLOGY OF EXPERIMENTAL AND HUMAN TUMORSR35CA056591 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 1993 to 1999
–
NCI NIH HHS P01 CA080124NCI NIH HHS R24 CA085140NCI NIH HHS R24-CA85140NCI NIH HHS R35-CA56591NEI NIH HHS EY09269NEI NIH HHS R01 EY009269NHLBI NIH HHS HL57818NHLBI NIH HHS R01 HL057818NINDS NIH HHS NS33335NINDS NIH HHS R01 NS033335
6 · The paper itself

Abstract

Nitric oxide (NO) plays a critical role in vascular endothelial growth factor (VEGF)-induced angiogenesis and vascular hyperpermeability. However, the relative contribution of different NO synthase (NOS) isoforms to these processes is not known. Here, we evaluated the relative contributions of endothelial and inducible NOS (eNOS and iNOS, respectively) to angiogenesis and permeability of VEGF-induced angiogenic vessels. The contribution of eNOS was assessed by using an eNOS-deficient mouse, and iNOS contribution was assessed by using a selective inhibitor [l-N(6)-(1-iminoethyl) lysine, l-NIL] and an iNOS-deficient mouse. Angiogenesis was induced by VEGF in type I collagen gels placed in the mouse cranial window. Angiogenesis, vessel diameter, blood flow rate, and vascular permeability were proportional to NO levels measured with microelectrodes: Wild-type (WT) > or = WT with l-NIL or iNOS(-/-) > eNOS(-/-) > or = eNOS(-/-) with l-NIL. The role of NOS in VEGF-induced acute vascular permeability increase in quiescent vessels also was determined by using eNOS- and iNOS-deficient mice. VEGF superfusion significantly increased permeability in both WT and iNOS(-/-) mice but not in eNOS(-/-) mice. These findings suggest that eNOS plays a predominant role in VEGF-induced angiogenesis and vascular permeability. Thus, selective modulation of eNOS activity is a promising strategy for altering angiogenesis and vascular permeability in vivo.

Indexed as

AnimalsBlood CirculationCapillary PermeabilityEndothelial Growth FactorsFemaleHomeodomain ProteinsLymphokinesMaleMiceMice, Inbred C57BLMice, KnockoutNeovascularization, PhysiologicNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitric Oxide Synthase Type IIIEndothelial Growth FactorsHomeodomain ProteinsLymphokinesNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINitric Oxide Synthase Type IIINos2 protein, mouseNos3 protein, mouseRAG-1 proteinVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID11226286
PMCPMC30185
OpenAlexW1968719918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.